로딩 중…
StockDiggingStockDigging

Inspire Medical Systems, Inc.

INSP· NYSE
$42.59+3.57%
2026-06-18

Price Chart

Inspire Medical Systems, Inc.-67.16%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$1.23B
Revenue$915M
Net Income$131M
Total Assets$911M
Net Assets$792M
Employees1,333
Value
P/E9.36x
P/B1.55x
P/S1.34x
EV/EBITDA16.02x
FCF Yield7.88%
Profitability
ROE16.55%
ROA14.39%
Op. Margin5.61%
Revenue Growth1.62%
Earnings Growth-477.47%
Financial Health
Debt Ratio15.02%
Total Debt$30M
FCF$97M
Cash$99M
Current Ratio6.34x
Net Debt/EBITDA-0.96x
Performance
1Y Return-67.16%
1M Return0.14%
From 52W High-71.03%
1Y MDD-73.31%
Trading
Volume823,453 shares
Trading Value$34M
Per Share
EPS$5.02
BPS$26.99

Company Info

CEO Mr. Timothy P. Herbert
Employees 1,333
HQ Golden Valley, United States

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.